Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1RG-CART in Relapsed or Refractory Neuroblastoma
NCT02761915Phase 1Completed
- Sponsor
- Cancer Research UK
- Start
- Feb 2016
- Primary completion
- Dec 2020
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of 1RG-CART in neuroblastoma, sponsored by Cancer Research UK. Started Feb 2016; status: completed.
02
Drugs
1RG-CART
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT02761915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761915.